Literature DB >> 15227406

Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators.

J T Willerson1, S K Yao, J J Ferguson, H V Anderson, P Golino, L M Buja.   

Abstract

The conversion from stable to unstable angina and the further progression to myocardial infarction are usually associated with atherosclerotic plaque fissuring or ulceration at sites of coronary artery stenosis and subsequent development of a thrombus. This thrombus formation is initiated by platelet adhesion and aggregation; these, in turn, are promoted by the local release and accumulation of thromboxane A(2) and serotonin. This accumulation and the resulting platelet aggregation at sites of endothelial injury cause dynamic vasoconstriction. With time, the platelet-initiated thrombus expands to include white and red blood cells in a fibrin mesh. Thus, a fully occlusive coronary thrombus may develop and cause the progression from unstable angina to acute myocardial infarction, often Q-wave myocardial infarction. We believe that the connection between unstable angina and acute myocardial infarction is a continuum relative to the processes of coronary artery thrombosis and vasoconstriction. When the period of platelet aggregation or dynamic vasoconstriction at sites of endothelial injury and coronary stenosis lasts only a few minutes and is repetitive, unstable angina or non-Q wave myocardial infarction occurs. However, when complete coronary artery occlusion lasts for longer than 4 hours, a transmural or Q-wave myocardial infarction results. Recently, in experimental animal models with mechanically induced coronary artery stenoses and endothelial injury, we have found that other mediators, including adenosine diphosphate and thrombin, also contribute to coronary artery thrombosis. Moreover, in humans with limiting angina, we have identified spontaneous coronary blood flow variations in a pattern similar to the variations caused by alternating platelet attachment and dislodgement in experimental canine modes. In this review, we add information to our previous observations in order to present the possible mechanisms of conversion from chronic to acute coronary heart disease syndromes.

Entities:  

Year:  1991        PMID: 15227406      PMCID: PMC326348     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  17 in total

1.  Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.

Authors:  E K van den Berg; J M Schmitz; C R Benedict; C R Malloy; J T Willerson; G J Dehmer
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

2.  Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.

Authors:  J F Eidt; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  Am J Physiol       Date:  1989-09

Review 3.  Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.

Authors:  J T Willerson; P Golino; J Eidt; W B Campbell; L M Buja
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

4.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Authors:  J F Eidt; P Allison; S Noble; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.

Authors:  J H Ashton; J M Schmitz; W B Campbell; M L Ogletree; S Raheja; A L Taylor; C Fitzgerald; L M Buja; J T Willerson
Journal:  Circ Res       Date:  1986-11       Impact factor: 17.367

6.  Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.

Authors:  S K Yao; C R Benedict; M Rosolowsky; J McNatt; B Falinska; W B Campbell; L M Buja; J T Willerson
Journal:  J Mol Cell Cardiol       Date:  1991-04       Impact factor: 5.000

7.  Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease.

Authors:  G M Rubanyl; R L Frye; D R Holmes; P M Vanhoutte
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

8.  Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina.

Authors:  E J Eichhorn; P A Grayburn; J E Willard; H V Anderson; J B Bedotto; M Carry; J K Kahn; J T Willerson
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

9.  Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.

Authors:  J H Ashton; C R Benedict; C Fitzgerald; S Raheja; A Taylor; W B Campbell; L M Buja; J T Willerson
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

10.  Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients.

Authors:  P Golino; F Piscione; J T Willerson; M Cappelli-Bigazzi; A Focaccio; B Villari; C Indolfi; E Russolillo; M Condorelli; M Chiariello
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

View more
  1 in total

Review 1.  The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.

Authors:  Prasanna Ekambaram; Wanyu Lambiv; Rosanna Cazzolli; Anthony W Ashton; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.